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Abstract
One quadrillion synapses are laid in the first two years of postnatal construction of the human brain, which are then pruned
until age 10 to 500 trillion synapses composing the final network. Genetic epilepsies are the most common neurological
diseases with onset during pruning, affecting 0.5% of 2–10-year-old children, and these epilepsies are often characterized by
spontaneous remission. We previously described a remitting epilepsy in the Lagotto romagnolo canine breed. Here, we
identify the gene defect and affected neurochemical pathway. We reconstructed a large Lagotto pedigree of around 34
affected animals. Using genome-wide association in 11 discordant sib-pairs from this pedigree, we mapped the disease
locus to a 1.7 Mb region of homozygosity in chromosome 3 where we identified a protein-truncating mutation in the Lgi2
gene, a homologue of the human epilepsy gene LGI1. We show that LGI2, like LGI1, is neuronally secreted and acts on
metalloproteinase-lacking members of the ADAM family of neuronal receptors, which function in synapse remodeling, and
that LGI2 truncation, like LGI1 truncations, prevents secretion and ADAM interaction. The resulting epilepsy onsets at
around seven weeks (equivalent to human two years), and remits by four months (human eight years), versus onset after
age eight in the majority of human patients with LGI1 mutations. Finally, we show that Lgi2 is expressed highly in the
immediate post-natal period until halfway through pruning, unlike Lgi1, which is expressed in the latter part of pruning and
beyond. LGI2 acts at least in part through the same ADAM receptors as LGI1, but earlier, ensuring electrical stability
(absence of epilepsy) during pruning years, preceding this same function performed by LGI1 in later years. LGI2 should be
considered a candidate gene for common remitting childhood epilepsies, and LGI2-to-LGI1 transition for mechanisms of
childhood epilepsy remission.
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Introduction
Postnatal mammalian brain development proceeds in three
phases the first of which is construction of the primary neural
network (ages zero to two years in humans, zero to one week in
mice, and estimated zero to one to two months in dogs). In
humans, this phase generates a network of approximately one
quadrillion synapses. The second phase, pruning (ages two to 10
years in humans, seven to 17 days in mice, and estimated two to
four months in dogs), is chiefly characterized by massive removal
of unneeded or otherwise inappropriate synapses, almost half the
original synapses. The third and final phase is the remainder of
life, during which synapse numbers remain stable [1–3].
Epilepsies are by far the most common neurological diseases in
children two to 10 years of age, the three most common of which
are Rolandic Epilepsy, Panayiotopoulos syndrome, and Childhood
Absence Epilepsy (CAE). The first two of these three syndromes
are focal-onset epilepsies where seizures start from defined brain
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regions, while CAE is a generalized epilepsy where seizures appear
to start simultaneously from all brain regions. All three syndromes
share a remarkable feature of remission after age 10, i.e. after
network pruning is complete [4]. All three are genetically complex
syndromes, and paucity of gene information has impeded their
understanding, including how and why they remit. To date, a few
ion channel mutations (e.g. in GABRG2, CACNA1H) have been
found in CAE, accounting for far less than 1% of patients with this
syndrome [5].
While the above three syndromes begin and end during the
pruning phase of neurodevelopment in the vast majority of cases,
other genetic epilepsies begin near or after the end of this phase,
i.e. after age eight in most cases. These include the generalized
Juvenile Myoclonic Epilepsy (JME) (to date with mutations in the
EFHC1 or GABRA1 genes; penetrance ,50%) [6,7] and the focal-
onset Autosomal Dominant Lateral Temporal Lobe Epilepsy
(ADLTE) (also called Autosomal Dominant Partial Epilepsy with
Auditory Features) with mutations in the LGI1 gene [8]
(penetrance 67%) [9]. JME is generally a non-remitting lifelong
epilepsy [10]. Remission rate in ADLTE has not been determined,
although the literature indicates that most cases remain on seizure
medications, unlike Rolandic epilepsy, e.g., where the vast
majority do not [10,11].
In the present work, we show that mutation of the Lgi2 gene, a
gene closely related to Lgi1, causes remitting focal-onset epilepsy in
dogs between ages one and four months, which is equivalent to
human two to eight years. LGI2 belongs to a family of four closely
related neuronal proteins including the well-studied LGI1. We
report functional and expression studies of LGI2, which,
combined with previous LGI1 studies, suggest a novel concept
of the basis of remission common in childhood epilepsy.
Results
Focal-onset epilepsy in the Lagotto Romagnolo canine
breed is associated with a truncating mutation of the
Lgi2 gene
The Lagotto Romagnolo is an ancient curly-haired water dog
(water dogs, or water spaniels, originally served to retrieve game
falling in water), which was selected in Italy to become an excellent
truffle hunter. The popularity of the breed fluctuated with the
truffle industry and in the early 1970s underwent a strong genetic
bottleneck to near extinction, when a group of dog lovers decided
to save it. The breed has since gained popularity for reasons
unrelated to truffle or water hunting, and its numbers are in the
thousands spread across most developed countries (http://www.
lagottoromagnolo.org/).
The breed is affected by an epilepsy, Benign Familial Juvenile
Epilepsy (BFJE), described in detail in reference [12]. Onset is at
five to nine weeks of age, and the epilepsy invariably completely
remits by four months of age. Remission is so reliable that the
epilepsy is considered by many breeders as an unfortunate
particularity of the breed and often disregarded. The seizures
consist of whole-body tremors sometimes associated with alter-
ation of consciousness. Electroencephalography (EEG) reveals
unilateral epileptic discharges in central-parietal and occipital
lobes, and magnetic resonance imaging (MRI) is normal. During
the months with epilepsy the animals are often ataxic, but this
resolves completely as the seizures disappear [12].
Towards the goal of mapping and identifying the BFJE gene we
first reconstructed a large multinational Lagotto pedigree from
which an example with 212 Finnish dogs including 34 cases is
shown in Figure S1. The dogs live in homes as private pets, often
in different countries in Europe, or were still with their breeders.
Disease segregation suggested autosomal recessive inheritance
(Figure S1). Next, we performed a single nucleotide polymorphism
(SNP) genome-wide association study with DNA from 11 of the
affected dogs and 11 unaffected littermates (discordant sib-pairs)
(Figure S1) and found very strong association in a region of
chromosome 3 (CFA3), peaking at the marker at base-pair
89159216 (Praw 0.000035; Pgenomewide 0.08) (Figure 1A and 1B).
There was no significant association at any other genomic locus,
the next best association being over 100-fold less significant
(Figure 1A). Genotype analysis around the 89159216 SNP
revealed a 1.7 Mb block of homozygous SNPs between markers
at 87.3 Mb and 89.0 Mb in the 11 cases and none of the controls
(Figure 1B). This region contains nine genes, including Lgi2.
Sequencing Lgi2 revealed an exonic homozygous protein-truncat-
ing sequence change, c.1552A.T (p.K518X), in all 11 affected
and none of the 11 unaffected animals (Figure 1C). Genotyping a
cohort of 140 dogs for the 89159216 SNP, for the Lgi2 c.1552
sequence change, and for three additional SNPs from the
homozygous region revealed extremely high associations including
Praw 4.47610
216 at 89159216 and Praw 1.05610
223 (the highest
association) at Lgi2 c.1552 (Table 1). These results strongly
suggested that Lgi2 c.1552A.T (p.K518X) is the BFJE mutation.
Next we studied segregation of the sequence change in the
pedigree. Of the 28 affected dogs from which we had samples, 26
(93%) were homozygous Lgi2 c.1552T (p.518X) (i.e. homozygous
for the nonsense codon), two were heterozygous (7%), and none
was homozygous for the wild-type (wt) A nucleotide. The two
affected dogs that were heterozygous were also heterozygous for
the 13 SNP haplotype around the Lgi2 locus, and we found no
evidence for compound heterozygosity as all other variants in the
gene were synonymous (Table S1). These results suggested that if
the Lgi2 c.1552A.T (p.K518X) change is the BFJE mutation, it
can, in a minority of cases, cause the epilepsy heterozygously. To
explore this further, we screened an independent set of 36 sporadic
Lagottos and found three homozygous for c.1552T, 14 heterozy-
gous (39%), and 19 wild-type (wt). All three dogs homozygous for
c.1552T had the syndrome, as did one of the carriers (7%),
appearing to confirm the 7% rate of disease through heterozy-
gosity, assuming that Lgi2 c.1552A.T (p.K518X) is causative.
Author Summary
Major remodeling of the neuronal synaptic network occurs
during childhood. The quadrillion synapses formed till the
end of age two are trimmed to 500 trillion by age 10
through a selective process of strengthening of ideal
connections, removal of redundant ones, and formation of
new contacts. Very little is known about the basic
mechanisms that direct this massive reorganization that
leads to the adult brain. The most common epilepsies of
humans occur in childhood and are characterized by
remission prior to adulthood. Not much is known about
their genetics and basic remission mechanisms. We
describe here a canine equivalent disease and identify
the defective gene, Lgi2. We show that the gene product is
a secreted protein and interacts with neuronal ADAM
receptors known to be involved in the regulation of
synaptic remodeling in the developing brain. Our work
sheds important light on the basic mechanisms of the
most common neurological disease of children and
discloses processes of epilepsy remission. The identifica-
tion of the first focal epilepsy gene in dogs has also
enabled the development of a genetic test to identify
carriers for breeding purposes.
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Among 112 unaffecteds of the genotyped 140 dogs, 69 were
homozygous for the wt A nucleotide, 41 were heterozygous, and
two, 1.8%, were homozygous for c.1552T (OR=532, 95%CI:
95.0-5747.1 and p= 1.05610223). The latter two may be mis-
specified as unaffected - clinical information on many of the dogs
in the pedigree was obtained through retrospective questionnaires,
and it is possible that a breeder missed seizures, as the epilepsy in
some cases is mild and short-lived [2]. Alternatively, these two
cases may represent incomplete penetrance, assuming, again, that
the sequence change we identified is causative. Similarly, other
recent recessive gene discoveries indicate incomplete penetrance
including canine lens luxation [13], degenerative myoelopathy
[14] and a form of neuronal ceroid lipofuscinosis [15].
At this point, there were two possibilities. Either Lgi2
c.1552A.T (p.K518X) is the BFJE mutation with an incomplete
penetrance in a minority of cases, or it is not the causative variant.
To gather more data we proceeded with functional studies of the
consequences of the truncating sequence change on the LGI2
protein.
Lgi2 c.1552A.T (p.K518X) truncation prevents LGI2
secretion and action on neuronal ADAM receptors
We first determined whether the c.1552A.T sequence change
prevents Lgi2 mRNA expression, e.g. through mRNA instability.
RT-PCR experiments showed no mRNA reduction (Figure 2).
LGI2 belongs to a family of neuronally secreted proteins (LGI1
to LGI4) conserved across mammals and composed of N-terminal
leucine-rich repeats (LRR) and C-termini containing seven EPTP
repeats [3]. K518X truncates LGI2 within the seventh EPTP
repeat (exon 8 of the gene) (Figure S2). Similar mutations
truncating LGI1 in the EPTP repeats in humans, including in
the seventh repeat, cause ADLTE, the human epilepsy with most
commonly onset after age eight and persistence through
adulthood. Where studied, the vast majority of LGI1 mutations,
truncating or otherwise, prevent secretion of the protein encoded
by the mutant allele, and ADLTE is therefore usually a disease due
to lack of neuronal secretion of half the required amount of LGI
[11,16,17]. We asked whether the LGI2 K518X truncation
prevents LGI2 secretion. We performed western blot experiments
with V5-tagged wt and mutant LGI2 transfected in HEK293 cells
and found that while both proteins were present in cell lysates only
wt LGI2 was found in the culture medium (Figure 3), indicating
that the truncation prevents secretion.
Following secretion, LGI1 interacts with a subfamily of the
ADAM (a-disintegrin-and-metalloproteinase) family of neuronal
membrane proteins [18,19]. Members of this subfamily, AD-
AM11, ADAM22 (post-synaptic), and ADAM23 (pre-synaptic),
lack the metalloproteinase domain that other ADAMs use to
convey extracellular signals intracellularly [19]. To determine
whether LGI2 also binds ADAM22, ADAM23 and ADAM11
following secretion, we performed immunofluorescent cell surface-
binding assays [18] in permeabilized and non-permeabilized cells
by co-expressing wt or truncated LGI2 with different ADAMs. Wt
LGI2 was secreted and then bound ADAM22, ADAM23 and
ADAM11 expressed on the cell surface (ADAM11 result not
shown). Truncated LGI2 was not secreted and did not bind the
ADAMs (Figure 4A–4B). We also performed co-immunoprecip-
itation in rat brain and found that both Adam22 and Adam23
antibodies co-precipitated Lgi2 (Figure 5). In summary, wt LGI2
binds the same ADAM substrates of LGI1 following secretion, and
the Lagotto K518X mutation prevents secretion and ADAM
interaction, in the same fashion as the well-characterized
truncating LGI1 epilepsy mutations.
Summarizing the results to this point, the genome-wide
association study revealed a highly significant association in the
vicinity of Lgi2, an extremely strong association (p = 1.05610223)
with the protein-truncating c.1552A.T (p.K518X) sequence
change in the gene, and no significant association with any other
locus. Lgi2 is a close homologue of the epilepsy (ADLTE) gene
LGI1, and the Lgi2 truncating mutation is closely similar to the
most common type of epilepsy-causing mutations in LGI1. The
consequence of the truncation on Lgi2 is identical to the
consequence of truncation on LGI1, prevention of neuronal
secretion and binding to ADAM receptors, which is presently the
most favored mechanism of epileptogenesis in ADLTE. Finally,
LGI1 mutations, including truncation mutations, are non-pene-
trant in 33% of individuals, compared to 1.8% non-penetrance in
the case of the canine Lgi2 truncation. Considering all the above,
we believe the data meet the burden of proof that Lgi2 c.1552A.T
(p.K518X) is the BFJE mutation. BFJE is transmitted in imperfect
Mendelian fashion. In the vast majority of cases, 93%,
homozygous mutation is required for the disease to manifest. In
a minority, 7%, heterozygosity suffices. Conversely, 1.8% of dogs
may be resistant to seizing despite homozygous mutation. Finally,
Table 1. Four highly-associated SNPs spread across the
linked 1.7 Mb homozygosity region, together with the
c.1552A.T mutation, were genotyped and tested for
association from 28 BFJE cases and 112 healthy controls.
Marker Position OR 95% CI P
BICF2G630354291 87328476 76.5 15.1-1870.5 4.47E-13
Lgi2 A1552T 88033499 532.1 95.0-5747.1 1.05E-23
BICF2S23524395 88092392 5.1 0.97-125.3 0.07
BICF2G630355625 88826870 66.9 17.6-476.8 8.14E-15
BICF2G630355982 89135642 68.6 20.9-290.2 4.47E-16
The strongest association is with c.1552A.T mutation confirming that Lgi2 is
the causative gene in the region.
doi:10.1371/journal.pgen.1002194.t001
Figure 2. Expression of the mutant Lgi2 transcript is normal.
Total RNA extracted from blood of a healthy (c.1552A/A), a carrier
(c.1552A/T), and an affected (c.1552T/T) Lagotto Romagnolo, as well as
from the cerebellum of a healthy (1552A/A) Saluki (referred as SB) was
transcribed into cDNAs for amplification by PCR with Lgi2 exon-specific
primers. The truncation mutation does not alter expression level of Lgi2.
doi:10.1371/journal.pgen.1002194.g002
Figure 1. Mapping and identification of the benign focal juvenile epilepsy mutation in Lagotto Romagnolo. A) Genome-wide association
analysis maps the disease locus to CFA3 with the strongest association at a SNP at position 89,159,216 (Praw = 0.000035 and Pgenome-wide = 0.08). B) A
1.7 Mb homozygous block spanning from 87.3 Mb to 89.0 Mb is present in affected dogs (bottom set of 11 dogs) and not in unaffected dogs (top set
of 11 dogs). C) Sequencing of the Lgi2 coding regions revealed a homozygous c.1552A.T mutation that causes a premature stop codon in exon 8,
resulting in truncation of the last 12 amino acids in the affected cases.
doi:10.1371/journal.pgen.1002194.g001
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we found no dog with homozygous wt genotype at Lgi2 c.1552 that
has BFJE.
Lgi2 is highly expressed during the first phase of
postnatal development (neural network construction
phase) and diminishes and plateaus during the network
pruning phase
Mouse studies show that LGI1 starts being expressed midway
through the synapse pruning phase of brain development (after
postnatal day 13 (p13)), and gradually increases to reach high and
stable adult levels by the end of this phase (after p17) [20,21]. Not
surprisingly, the mice lacking LGI1 develop seizures after mid-
phase pruning [22] and the great majority of human patients with
ADLTE have onset of their epilepsy after age 10 years, the end of
the pruning phase in humans, with the remaining few having
initial seizures in the latter half of this phase [11,16,17]. However,
it is worth noting that the very first seizures in ADLTE are often
auditory seizures, which might not initially be appreciated to be
seizures and might have occurred earlier than what is currently
Figure 3. Mutant LGI2 is not secreted in cell cultures. HEK293 cells were transfected with human V5-tagged wt and p.K534X mutant LGI2
clones. Aliquots of lysed cells (lanes 1&2) and culture media (lanes 3&4) were harvested, concentrated, and analyzed with anti-V5 and anti-GADPH
antibodies to follow expression of the recombinants. Only wild-type LGI2 protein is found in culture media indicating that the K534X mutation
prevents secretion.
doi:10.1371/journal.pgen.1002194.g003
Figure 4. Wild-type (wt) LGI2, like LGI1, binds to ADAM22 and ADAM23 on the cell surface. Indicated cDNAs were co-transfected into
COS7 cells, and after 24 hours surface-bound LGI1-Flag and LGI2-V5 (red) were labeled before cell permeabilization and staining of the HA-tagged
ADAM22 (A) and ADAM23 (B) proteins (green). Wt Lgi1 and LGI2 bound to both cell surface ADAM receptors, whereas mutant LGI2 was not secreted
and did not bind the receptors.
doi:10.1371/journal.pgen.1002194.g004
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documented in the literature. Because BFJE occurs only in ages
equivalent to human two to eight years, we sought to determine
whether expression of LGI2 differs from that of LGI1. We
examined the expression profile of all four LGI genes in adult
tissues using the human GeneSapiens expression database [4] and
found that the amount of LGI2 in adult brain is much lower than
that of the other three (Figure S3). We next chased Lgi2 expression
levels in mouse forebrain and cerebellum by performing
quantitative RT-PCR every other day from birth till 27 days.
Lgi2 expression in the cerebellum did not change appreciably over
this time (Figure 6A). Expression in the forebrain, on the other
hand, was highest at birth and through phase one of postnatal
development (neural network construction phase), and declined to
half the original amount by midway through the pruning phase
(Figure 6B). Considering that BFJE occurs only during the pruning
phase, these results suggest that LGI2’s main functions take place
in the developmental phase preceding the phase in which the
epilepsy occurs.
Discussion
Epilepsy is a common symptom of insult to the brain from
various causes including tumors, trauma, stroke, and neurodegen-
erative disease. For example, the most common cause of epilepsy
in the elderly is stroke and in neonates hypoxic ischemic
encephalopathy. However, epilepsy can also be a disease onto
itself, where seizures are the only or preponderant neurological
symptom, i.e. the brain is normal except for its propensity to seize.
Resolving the basic mechanisms of this type of ‘pure’ epilepsy is
expected to provide the clearest insights into epileptogenesis. As
mentioned, these pure epilepsy syndromes (sometimes called
idiopathic, Greek for ‘disease onto itself’) are the commonest
neurological diseases with onset in two to 10 year-old children, and
in this age group most are genetic, commonly polygenic, and often
characterized by remission in adolescence [5].
Genetic-idiopathic epilepsy syndromes are the most common
neurological diseases of dogs, in some breeds 10 times more
common than in humans [23]. In the present work we identify the
first of the canine idiopathic epilepsy genes, in a remitting
syndrome with onset and offset equivalent to human childhood
two to 10 years. This epilepsy can now be eliminated from the
Lagotto through selective breeding. Carrier frequency of the
mutation is very high. We tested 576 Lagottos from three different
countries and found a carrier rate of 32% (Table S2). On the other
hand, the mutation appears restricted to this particular epilepsy in
this particular breed. We tested 121 epileptic dogs from 40
different breeds, including Barbets, a Lagotto-related French water
spaniel breed afflicted with a separate epilepsy, and none carries
the BFJE mutation (Table S3).
Genetic epilepsies of various types, as simple or complex traits,
are highly enriched in various canine breeds, including Miniature
Wirehaired Dacshunds [24], Finnish Spitzs [25] and Belgian
Shepherds [23] due to pure-breeding. Each of these traits is in
genetic isolation within its corresponding breed. This vastly
improves signal to noise ratio in genetic studies compared to
human populations [26], which should facilitate mapping epilepsy
genes. The Lagotto themselves segregate a second epilepsy with
onset in adulthood completely distinct from BFJE [12]. We have
established that this second epilepsy is not associated with the
BFJE mutation (Table S1), and are presently mapping its gene(s).
Five out of the six adult-onset cases with persistent seizures in our
pedigree were genotyped and only one of them was homozygous
for the BFJE mutation. However, the puppyhood history of this
case is unknown and it was impossible to confirm retrospectively
whether this case has also had BFJE. This case has an affected
littermate with classical BFJE who is homozygous for the
mutation. On the other hand, all the other genotyped adult-onset
dogs were wildtypes strongly suggesting that this form of epilepsy
has its own genetic cause, and that this single homozygous case
may have suffered from both BFJE and the adult-onset form of
epilepsy.
The BFJE gene is a homolog of the human epilepsy gene LGI1.
LGI1 is neuronally secreted and binds three metalloproteinase-
lacking ADAM receptors. Significant progress has started to be
made in elucidating LGI1’s functions at these receptors. LGI1
interaction with post-synaptic ADAM22 strengthens and stabilizes
ADAM22-containing synapses [18,21,22]. Interaction with pre-
synaptic ADAM23 enhances neurite outgrowth from ADAM23-
containing axons [27]. Through its seven-bladed b-propeller
structure (encoded by the EPTP repeats), LGI1 simultaneously
binds ADAM23 and ADAM22, pulling pre and post-synaptic
membranes together, physically stabilizing synapses containing
these two proteins and strengthening neurotransmission in these
synapses [22]. Importantly, LGI1 regulates neuronal terminal
pruning and maturation, again through a combined pre and post-
synaptic action [21].
Humans not expressing or secreting LGI1 from one allele
develop epilepsy starting in the vast majority of cases after age
eight and seeming to persist in adulthood in many cases. Mice
completely lacking LGI1 are normal until midway through the
pruning phase of brain development (,P13), when LGI1 would
normally have started being expressed, after which they develop
seizures that progressively worsen as LGI1’s amounts would
normally have progressively increased, and die of violent
convulsions by four weeks of life [22,28,29]. These results show
that LGI1 is a vital protein, vital specifically in protecting the brain
against seizures. In humans its partial loss results in epilepsy, and
only epilepsy, and in the mice its complete loss leads to death from
epilepsy prior to the presence of any other neurological symptom.
This vital anti-epileptic role is mediated at least in part through the
above three ADAM receptors suggesting that the LGI1-ADAM
Figure 5. LGI2 interacts with ADAM22 and ADAM23 in rat
brain. Western blotting shows that antibodies against ADAM22 or
ADAM23 co-precipitate Lgi2 in brain lysates.
doi:10.1371/journal.pgen.1002194.g005
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Figure 6. Developmental expression of LGI2 in mouse brain. Mouse cerebelli (A) and forebrains (B) were harvested postnatally every other
day for the first four weeks of life (except days 5 and 17) and Lgi2 transcript levels were measured by quantitative RT-PCR. Lgi2 expression is at the
highest levels in the forebrain at birth but decreases significantly after p13. In the cerebellum Lgi2 levels remain stable. Trendline is shown by dashed
lines.
doi:10.1371/journal.pgen.1002194.g006
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complexes and their related pathways are essential components of
neural network electrical stability in the maturing and mature
brain.
We show in our study that lack of secretion of LGI2 is also
associated with epilepsy, at an earlier stage of development, and
secreted LGI2 interacts with the same ADAM receptors as LGI1,
suggesting that LGI2 participates in protecting the brain against
seizures during the pruning phase of neurodevelopment at least in
part through the same system utilized by LGI1 in the subsequent
phase. Importantly, LGI2 expression is highest in the phase
preceding pruning and epilepsy. This suggests that the LGI2 anti-
epileptic activity anticipates the pruning phase, i.e. LGI2 acts
during the network construction phase to help prepare a network
that will not seize during the pruning phase. To date, there has
been no compelling evidence-based theory of why so many
epilepsies of childhood begin and end with the start and end of the
pruning phase. Our results, combined with the body of LGI1
work, suggest the following. Construction of the initial network
includes mechanisms, in which LGI2 participates, that ensure that
the network will not seize during the pruning phase. Defects in
these anticipatory anti-epileptic processes result in epilepsy as the
massive changes of the pruning phase commence. The pruning
phase itself encompasses mechanisms, in which LGI1 participates,
that ensure that the pruned and remodeled network to serve the
rest of the animal’s life is electrically stable. These mechanisms are
able to correct or compensate for earlier instabilities, e.g. those
introduced by LGI2 deficiency, resulting in the remission that
characterizes so many childhood idiopathic epilepsies.
Of the remaining two LGI proteins, LGI4 appears not to have a
major role in the central nervous system. Instead, its chief function
appears to be in regulating neuron-Schwann cell interaction, its
secretion defect resulting in inability of Schwann cells to correctly
myelinate peripheral nerves, resulting in peripheral nervous system
hypomyelination and the murine claw-paw phenotype [30].
LGI3’s function, on the other hand, appears to be similar to that
of LGI1, as there is evidence that like LGI1 it regulates neurite
outgrowth [31]. LGI3 starts being expressed at p7 in mouse, i.e. at
the very start of the pruning phase, has steady and high expression
throughout the brain in adulthood, and interacts with ADAM22
and ADAM23, as well as presynaptic SNARE complexes [31–34].
However, LGI3 does not rescue the LGI1 knockout mouse
epilepsy [22], and therefore the two proteins are at least not
interchangeable.
Four phenotypes have been associated with LGI1. The first is
normalcy in the up to 33% of patients with heterozygous
mutations in ADLTE families. Second is ADLTE in the remaining
patients with heterozygous LGI1 mutations. The third is the recent
realization that the acquired autoimmune epilepsy syndrome
Limbic Encephalitis, long thought to be due to auto-antibodies
against a potassium channel, is in fact due to an auto-antibody
against LGI1. As expected, all patients with this condition are over
10 years of age [35]. The final phenotype is the intractable and
fatal mid-pruning phase-onset murine epilepsy caused by complete
LGI1 deficiency. In the clinic, we not infrequently encounter
previously normal children with onset of explosive catastrophic
epilepsy. Homozygous mutations in LGI1 (and possibly LGI3)
should be considered as a possible cause of this presentation.
The phenotype associated with LGI2 in the present study is of a
remitting epilepsy with focal onset and centrotemporal and
occipital spikes on EEG, occurring within the age range equivalent
to human two to 10 years. Two of the most common human
epilepsy syndromes occur in this age range, Rolandic Epilepsy,
which is focal in onset with centrotemporal spikes on EEG,
and Panayiotopoulos Syndrome, again focal-onset, with both
centrotemporal and occipital spikes on EEG. LGI2 should be
considered a candidate gene in these common epilepsies.
Materials and Methods
Ethics statement
We have collected blood samples from privately owned pets for
our genetic studies and have a valid ethical permission for the
proposed blood sampling in the study, ESLH-2009-07827/Ym-23
(Oct 2009–Oct 2012) from the Animal Ethic Committee, The
State Provincial Office of Southern Finland, P.O. B150, 13101
Ha¨meenlinna.
Study population
Mapping of the benign focal juvenile epilepsy (BFJE) locus in
Lagotto Romagnolo was based on clinically studied litters from
Finland [12], German and Switzerland including 25 epileptic
puppies, 17 healthy littermates and 12 parents. Furthermore,
based on the retrospective questionnaire-based phenotype infor-
mation, we expanded our study cohort to a total of 112 healthy LR
dogs and 28 BFJE cases and collected also 36 sporadic dogs.
Additionally, the study population included also five adult-onset
epilepsy LR cases [12] and our clinically diagnosed juvenile
epilepsy cases from other breeds including Barbets, Collies and
German Shepherds (Table S1). Population-based allele and
genotype frequencies were estimated from a population of 576
Lagotto samples from three different countries (Table S2). EDTA-
blood samples were collected and genomic DNA was extracted
using a commercially available kit (Puregene, Gentra Systems,
Minneapolis, MN). The Finnish Kennel Club’s breeding database,
Koiranet, was utilized for pedigrees.
Genome-wide association study (GWAS)
Altogether 22 dogs including seven discordant full sibs and four
half-sibs were selected for GWAS. Genotyping was performed
with Affymetrix’s Canine SNP Array version 1 containing 26,578
markers (Affymetrix, Santa Clara, CA). The SNP association
analysis was performed with PLINK software [36] with the criteria
of MAF ,0.05, call rate .75% and ,25% of missing genotypes
in individual dogs. After applying these filters, 17,273 SNPs
remained in the analysis for all dogs. Genome-wide significance
was ascertained through 10 000 random permutations of epilepsy
phenotype.
Mutation screening
Exons and splice junctions were amplified by PCR with primers
listed in Table S4. The PCR products were purified with ExoSAP-
IT kit (USB Corporation, Cleveland, Ohio) and sequenced with an
ABI Prism 3730xl DNA analyzer (Applied Biosystems, Foster City,
CA). To confirm that the Lgi2 is the causative gene in the
associated 1.7 Mb region we sequenced four SNPs around the
associated homozygozity region together with the mutation in 112
healthy and 28 epileptic Lagottos. Odds ratio was calculated using
conditional maximum likelihood estimation and corresponding
95% CI was calculated from Fisher exact test. The calculations
were done with R statistical software package. Absence of the
mutation in other breeds was studied by sequencing epileptic cases
from altogether 40 different breeds (Table S3).
Transcript analyses
To study the effect of the nonsense mutation on the stability of
Lgi2 transcript, total RNA was isolated from an affected and a
healthy Lagotto dog from peripheral blood using PAXgene Blood
RNA Kit (PreAnalytix, Hombrechtikon, Switzerland). Total RNA
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isolated from the cerebellum of a Saluki puppy euthanized due to
hernia diaphragmatica was used as an amplification control.
cDNA synthesis was performed using the High Capacity RNA-to-
cDNA kit (Applied Biosystems, Foster City, CA), and exon 4- and
exon 8-specific primers (Table S4) were used to amplify Lgi2 by
PCR. Transcriptional profiling of the LGI2 mRNA expression
levels across a large number of human tissues was retrieved from
the public GeneSapiens (PMID: 18803840) database containing
data from a meta-analysis of 9873 samples analyzed using the
Affymetrix gene expression microarrays [37].
Cell culture, transfections, and Western blotting
To study the effect of the mutation on the expression and
secretion of LGI2 in cell culture, we obtained the human LGI2
clone from GeneScript Corporation (Piscataway, NJ). The mutant
LGI2 clone including the premature stop codon (p.K534X
corresponding to canine p.K518X) was prepared from the wt
clone and both were cloned into the pcDNA3.1D/V5-His vector
in frame with the C-terminal V5-tag using pcDNA3.1 Directional
TOPO Expression Kit (Invitrogen, Carlsbad, CA). The recombi-
nant constructs were confirmed by sequencing. HEK293 cells
were grown in DMEM-GLUTAMAX medium (Gibco Laborato-
ries, North Andover, MA) supplemented with 10% fetal calf serum
(FCS), 100 IU/ml penicillin, 100 mg/ml streptomycin and 1 mM
Sodium Pyruvate and transiently transfected with the FuGENE 6
reagent (Roche Diagnostics, Indianapolis, IN) according to the
manufacturer’s instructions. Expression of the wt and mutant LGI2
were analyzed 48 hours after transfection by immunostaining on
Western blots with anti-V5 antibodies from cell lysates and culture
media. Media samples were concentrated 100-fold with Sentricon-
10k concentrator (Millipore, Billerica, MA) before loading onto
gel. GADPH was used as internal loading control using anti-
GADPH antibodies. Proteins were visualized using the enhanced
chemiluminescence method.
Cell-surface binding assay
COS7 cells were co-transfected using human V5-tagged wt
LGI2B or LGI2B p.K534X mutant or rat FLAG-tagged wt LGI1
with mouse HA-tagged Adam22 or Adam23. LGI1 and ADAM
clones were described previously [18]. 24 hours after transfection,
cells were fixed with 2% paraformaldehyde at RT for 10 min,
blocked with PBS containing 10 mg/ml BSA and stained with
anti-Flag or anti-V5 antibodies followed by Cy3-conjugated
secondary antibody without permeabilization to visualize only
the cell-surface bound LGIs. Then, the cells were permeabilized
with 0.1% Triton X-100 for 10 min, blocked with PBS containing
10 mg/ml BSA, and stained with anti-HA polyclonal antibody,
followed by Alexa488-conjugated secondary antibody. Fluorescent
images were taken with a confocal laser microscopy system (Carl
Zeiss LSM 510; Carl Zeis, Oberkochen, Germany).
Developmental expression
To study the developmental expression of the Lgi2 transcript a
colony of C57/BL6 mouse was established for tissue and RNA
harvesting. Every other day after birth (except days 5 and 17) one
mouse was sacrificed and the forebrain of the cerebrum and the
cerebellum were harvested and deep-frozen in liquid nitrogen
before total RNA isolation by the QIAGEN RNeasy mini kit. The
isolated RNA was DNase I-treated before RT-PCR by the
SuperScript First-Strand Synthesis System (Invitrogen, Carlsbad,
CA). Quantitative PCR was performed using a SYBR Green
method with MxPro-3005P multiplex Quantitative PCR systems.
Lgi2-specific forward, atgtgtacgtggccatcgctca, and reverse,
caaacttggtccagctctcgtcgta, primers were used for amplification.
Supporting Information
Figure S1 Segregation of the LGI2 c.1552A.T mutation in a
Finnish Lagotto Romagnolo pedigree, which is a part of our larger
and more complex multinational pedigree. Squares denote males,
circles females. The benign focal juvenile epilepsy (BFJE) cases and
adult-onset epilepsy cases are marked with black and red,
respectively. Dogs with DNA samples are marked according to
the Lgi2 mutation genotypes (A/A, wild type; A/T, heterozygous
carrier; T/T, homozygous for epilepsy mutation). Clinically
studied litters are numbered 1-12. Red arrows indicate the two
BFJE cases that were carriers of the mutation while all other BFJE
cases were homozygous for the mutation. Four out of the five
adult-onset cases genotyped were wild-types. The puppyhood
history of the only adult-onset case homozygous for the BFJE
mutation (T/T) remains unclear, however, the dog differs from the
other BFJE cases still having persistent seizures as an adult without
remission [12]. It is possible that this case may have had both
BFJE and the adult-onset epilepsy.
(TIF)
Figure S2 Alignment of human (NP_060646.2), chim-
panzee (XP_526541.1), dog (XP_545971.2), cow (XP_614279.2),
mouse (NP_659194.1,LGI2A), rat (XP_223494.4), chicken (XP_
001232758.1) and zebra fish (NP_001034730.1) LGI2 protein
sequences. The LRR domain is shown in grey, and the EPTP/EAR
repeats in yellow. The canine p.K518X mutation site at the end of
the protein is indicated by a red arrow.
(RTF)
Figure S3 Expression profiles of the LGI family members. Box
plot analysis of the median LGI1 (A), LGI2 (B), LGI3(C) and LGI4
(D) expression levels across different normal non-CNS tissues
(green) and healthy CNS tissues (red). The number of samples in
each category is shown in parentheses. The box refers to the
quartile distribution (25–75%) range, with the median shown as a
black horizontal line. In addition, the 95% range and individual
outlier samples are shown.
(PDF)
Table S1 The coding regions and splice sites were screened for
additional variants in the Lgi2 gene in two heterozygous affecteds
(LAG001 and LAG099) and a set of adult-onset epileptic Lagottos
or other puppies with juvenile epilepsy from other breeds
including Barbets, Collies and German Shepherds. Although several
variants were found none of them appear disease-causing.
(DOC)
Table S2 Genotype frequencies of the Lgi2 c.1552A.T
(p.K518X) mutation tested from Lagotto Romagnolo dogs in different
countries.
(DOC)
Table S3 The Lgi2 c.1552A.T mutation is breed-specific.
Mutation was screened altogether from 114 adult-onset epilepsy
cases and eight juvenile epilepsy cases that represented 40 different
breeds. None of the studied dogs carried the mutant allele present in
Lagottos.
(DOC)
Table S4 Primers used in the study.
(DOC)
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